Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Fentanyl transdermal - Janssen Pharmaceutical KK

Next Previous
X
Search
Drug Profile

Fentanyl transdermal - Janssen Pharmaceutical KK

Alternative Names: Durotep; JNJ-35685-AAA-G016; JNJ-35685-AAA-G021; JNS-020; JNS-020QD

Latest Information Update: 05 Nov 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Janssen Pharmaceutical KK
  • Developer Janssen Pharmaceutical KK; Janssen Research & Development
  • Class Amides; Benzene derivatives; General anaesthetics; Opioid analgesics; Piperidines; Small molecules
  • Mechanism of Action Opioid mu receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Pain
  • Discontinued Cancer pain

Most Recent Events

  • 28 Dec 2018 No recent reports of development identified for phase-I development in Pain(In volunteers) in USA (Transdermal)
  • 16 Jul 2016 No recent reports of development identified for phase-I development in Pain in Belgium (Transdermal, Patch)
  • 01 Jun 2016 Janssen Research & Development completes a phase I trial in Healthy volunteers in USA (NCT02617758)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top